Section 2: Risk Stratification of Patients with Adrenal Dysfunction and Osteoporosis
Course overview
Participants in Section 2 will be introduced to evidence-based knowledge essential for the risk stratification of patients with adrenal dysfunction and osteoporosis and the development of appropriate diagnostic, preventive, and therapeutic strategies commensurate with a patient’s ability to undergo and respond to dental care.
Objectives
After completing this section, the participant should be able to:
Discuss the current and accepted medical management of patients with adrenal dysfunction and osteoporosis
Identify disease-related, patient-related, and procedure-related factors that will impact on the dental management of patients with adrenal dysfunction and osteoporosis
Presenter(s)
Disclosure
It is the policy of the UT Health San Antonio Office of Continuing Dental Education to ensure balance, independence, objectivity and scientific rigor in all of its sponsored educational activities. All participating speakers, course directors, and planning committee members are required to disclose to the program audience any financial relationships related to the subject matter of this program. Relationships of spouse/partner with proprietary entities producing health care goods or services should be disclosed if they are of a nature that may influence the objectivity of the individual in a position to control the content of the CDE activity. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. Specific disclosure information for each speaker, course director, and planning committee member will be shared with the audience prior to the speaker’s presentation.
Continuing Dental Education Staff members have nothing to disclose.